Search - tctmd.com

Displaying 1 - 12 of 12

Sort: Relevancy | Date

News Daily News

Weight Loss Drugs Show Promise for Secondary Prevention in PAD

L.A. McKeown

February 04, 2026

News Opinion CV Team Dispatch

September 2024 Dispatch for the CV Team

L.A. McKeown

September 01, 2024

News Daily News

Kidney Events High in Older Patients After HF Hospitalization

L.A. McKeown

May 30, 2024

News Opinion CV Team Dispatch

November 2023 News Roundup

L.A. McKeown

November 01, 2023

News Daily News

Medtronic’s Renal Denervation System Fails to Sway FDA Advisory Panel

L.A. McKeown

August 23, 2023

News Daily News

AHA Urges More Home-Based Dialysis in Advanced Kidney Failure

Michael O'Riordan

August 18, 2022

News Conference News EuroPCR 2022

Registry Data Hint at MACE Benefit With Renal Denervation

Michael O'Riordan

May 17, 2022

News Conference News TCT 2021

Renal Denervation May Help Cut BP Meds, Sham-Controlled Trial Hints

Todd Neale

November 04, 2021

News Industry News

Boehringer Ingelheim and Lilly announce an academic collaboration with University of Oxford to investigate the effects of Jardiance® in adults with chronic kidney disease

April 26, 2018

News Daily News

Year in Review: Physicians Pick the Biggest News of 2017, in Interventional Cardiology and Beyond

Shelley Wood

December 26, 2017

News Daily News

Dialysis Patients with Complex Coronary Disease Fare Better at 5 Years with CABG vs PCI

Caitlin E. Cox

June 24, 2014

News Daily News

Model Suggests Renal Denervation Cost-effective for Resistant Hypertension

September 13, 2012

Advertisement

Weight Loss Drugs Show Promise for Secondary Prevention in PAD

September 2024 Dispatch for the CV Team

Kidney Events High in Older Patients After HF Hospitalization

November 2023 News Roundup

Medtronic’s Renal Denervation System Fails to Sway FDA Advisory Panel

AHA Urges More Home-Based Dialysis in Advanced Kidney Failure

Registry Data Hint at MACE Benefit With Renal Denervation

Renal Denervation May Help Cut BP Meds, Sham-Controlled Trial Hints

Boehringer Ingelheim and Lilly announce an academic collaboration with University of Oxford to investigate the effects of Jardiance® in adults with chronic kidney disease

Year in Review: Physicians Pick the Biggest News of 2017, in Interventional Cardiology and Beyond

Dialysis Patients with Complex Coronary Disease Fare Better at 5 Years with CABG vs PCI

Model Suggests Renal Denervation Cost-effective for Resistant Hypertension

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content